Wal-Mart Escapes Suit Over Misleading Migraine Meds
A California federal judge on Wednesday tossed a putative class action accusing Wal-Mart Stores Inc. of misleading customers into paying twice as much for its store-brand migraine medicine by marketing it...To view the full article, register now.
Already a subscriber? Click here to view full article